This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2001 Apr;107(8):945-6.

doi: 10.1172/JCI12704.

More weapons in the arsenal against ischemic retinopathy

E Keshet¹

Affiliations

PMID: 11306596
PMCID: PMC199562
DOI: 10.1172/JCI12704

Comment

More weapons in the arsenal against ischemic retinopathy

E Keshet. J Clin Invest. 2001 Apr.

. 2001 Apr;107(8):945-6.

doi: 10.1172/JCI12704.

Author

E Keshet¹

Affiliation

¹ Department of Molecular Biology, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel.

PMID: 11306596
PMCID: PMC199562
DOI: 10.1172/JCI12704

No abstract available

PubMed Disclaimer

Comment on

Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis.
Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, Bicknell R. Ziche M, et al. J Clin Invest. 1997 Jun 1;99(11):2625-34. doi: 10.1172/JCI119451. J Clin Invest. 1997. PMID: 9169492 Free PMC article.
Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.
Papapetropoulos A, García-Cardeña G, Madri JA, Sessa WC. Papapetropoulos A, et al. J Clin Invest. 1997 Dec 15;100(12):3131-9. doi: 10.1172/JCI119868. J Clin Invest. 1997. PMID: 9399960 Free PMC article.
Inducible nitric oxide synthase mediates the change from retinal to vitreal neovascularization in ischemic retinopathy.
Sennlaub F, Courtois Y, Goureau O. Sennlaub F, et al. J Clin Invest. 2001 Mar;107(6):717-25. doi: 10.1172/JCI10874. J Clin Invest. 2001. PMID: 11254671 Free PMC article.
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy.
Freeman K, Lerman I, Kranias EG, Bohlmeyer T, Bristow MR, Lefkowitz RJ, Iaccarino G, Koch WJ, Leinwand LA. Freeman K, et al. J Clin Invest. 2001 Apr;107(8):967-74. doi: 10.1172/JCI12083. J Clin Invest. 2001. PMID: 11306600 Free PMC article.

Similar articles

Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice.
Brooks SE, Gu X, Samuel S, Marcus DM, Bartoli M, Huang PL, Caldwell RB. Brooks SE, et al. Invest Ophthalmol Vis Sci. 2001 Jan;42(1):222-8. Invest Ophthalmol Vis Sci. 2001. PMID: 11133872
Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy.
Hardy P, Dumont I, Bhattacharya M, Hou X, Lachapelle P, Varma DR, Chemtob S. Hardy P, et al. Cardiovasc Res. 2000 Aug 18;47(3):489-509. doi: 10.1016/s0008-6363(00)00084-5. Cardiovasc Res. 2000. PMID: 10963722 Review.
Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease.
Vinores SA, Youssri AI, Luna JD, Chen YS, Bhargave S, Vinores MA, Schoenfeld CL, Peng B, Chan CC, LaRochelle W, Green WR, Campochiaro PA. Vinores SA, et al. Histol Histopathol. 1997 Jan;12(1):99-109. Histol Histopathol. 1997. PMID: 9046048
Transgenic mice model of ocular neovascularization driven by vascular endothelial growth factor (VEGF) overexpression.
Lakatos L. Lakatos L. Am J Pathol. 1998 May;152(5):1397-8. Am J Pathol. 1998. PMID: 9588908 Free PMC article. No abstract available.
Tissue responses to ischemia: local and remote responses for preserving perfusion of ischemic muscle.
Isner JM. Isner JM. J Clin Invest. 2000 Sep;106(5):615-9. doi: 10.1172/JCI10961. J Clin Invest. 2000. PMID: 10974011 Free PMC article. Review. No abstract available.

See all similar articles

Cited by

Glycolysis links reciprocal activation of myeloid cells and endothelial cells in the retinal angiogenic niche.
Liu Z, Xu J, Ma Q, Zhang X, Yang Q, Wang L, Cao Y, Xu Z, Tawfik A, Sun Y, Weintraub NL, Fulton DJ, Hong M, Dong Z, Smith LEH, Caldwell RB, Sodhi A, Huo Y. Liu Z, et al. Sci Transl Med. 2020 Aug 5;12(555):eaay1371. doi: 10.1126/scitranslmed.aay1371. Sci Transl Med. 2020. PMID: 32759274 Free PMC article.
Differential Effects of Cytopathic Hypoxia on Human Retinal Endothelial Cellular Behavior: Implication for Ischemic Retinopathies.
El-Tanani S, Yumnamcha T, Singh LP, Ibrahim AS. El-Tanani S, et al. Int J Mol Sci. 2022 Apr 12;23(8):4274. doi: 10.3390/ijms23084274. Int J Mol Sci. 2022. PMID: 35457092 Free PMC article.

References

1. Smith LE, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994;35:101–111. - PubMed
1. Michaelson IC. The mode of development of the vascular system of the retina with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc UK. 1948;68:137–180.
1. Aiello LP. Vascular endothelial growth factor in ocular fluid of patients with proliferative diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480–1487. - PubMed
1. Robinson GS, et al. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci USA. 1996;93:4851–4856. - PMC - PubMed
1. Aiello LP, et al. Suppression of retinal neovascularization in vivo by inhibition of VEGF using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA. 1995;92:10457–10461. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database